Company
Macromoltek
Revolutionizing Antibody Design
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
We use AI and computational modeling to design advanced antibodies, helping biotech and pharma partners accelerate innovation and improve therapeutic outcomes.
Loading relationship preview